These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33770206)

  • 21. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triton X-100-Modified Adenosine Triphosphate-Responsive siRNA Delivery Agent for Antitumor Therapy.
    Fan X; Zhao X; Su W; Tang X
    Mol Pharm; 2020 Oct; 17(10):3696-3708. PubMed ID: 32803981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ferritin-mediated siRNA delivery and gene silencing in human tumor and primary cells.
    Li L; Muñoz-Culla M; Carmona U; Lopez MP; Yang F; Trigueros C; Otaegui D; Zhang L; Knez M
    Biomaterials; 2016 Aug; 98():143-51. PubMed ID: 27187278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Novel vector preS1-tp fusion protein effectively inhibits hepatitis B virus replication and cccDNA synthesis by mediating hepatitis B virus targeting sequence small interfering RNA].
    Zeng YL; Gao F; Zhang C; Wei JF; Ma L; Ding GG; Li W; Shang J; Kang Y
    Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):126-132. PubMed ID: 33685080
    [No Abstract]   [Full Text] [Related]  

  • 25. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.
    Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J
    Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Lysosome-Activated Tetrahedral Nanobox for Encapsulated siRNA Delivery.
    Gao Y; Chen X; Tian T; Zhang T; Gao S; Zhang X; Yao Y; Lin Y; Cai X
    Adv Mater; 2022 Nov; 34(46):e2201731. PubMed ID: 35511782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective combination treatment of lung cancer cells by single vehicular delivery of siRNA and different anticancer drugs.
    Li J; Wang Y; Xue S; Sun J; Zhang W; Hu P; Ji L; Mao Z
    Int J Nanomedicine; 2016; 11():4609-4624. PubMed ID: 27695321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.
    Joo MK; Yhee JY; Kim SH; Kim K
    J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear-targeted siRNA delivery for long-term gene silencing.
    Li N; Yang H; Yu Z; Li Y; Pan W; Wang H; Tang B
    Chem Sci; 2017 Apr; 8(4):2816-2822. PubMed ID: 28553519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorescent carbon dots as an efficient siRNA nanocarrier for its interference therapy in gastric cancer cells.
    Wang Q; Zhang C; Shen G; Liu H; Fu H; Cui D
    J Nanobiotechnology; 2014 Dec; 12():58. PubMed ID: 25547381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporation of a Nuclear Localization Signal in pH Responsive LAH4-L1 Peptide Enhances Transfection and Nuclear Uptake of Plasmid DNA.
    Xu Y; Liang W; Qiu Y; Cespi M; Palmieri GF; Mason AJ; Lam JK
    Mol Pharm; 2016 Sep; 13(9):3141-52. PubMed ID: 27458925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hollow Inorganic Nanoparticles as Efficient Carriers for siRNA Delivery: A Comprehensive Review.
    Varshosaz J; Taymouri S
    Curr Pharm Des; 2015; 21(29):4310-28. PubMed ID: 26323421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing.
    Tambe V; Thakkar S; Raval N; Sharma D; Kalia K; Tekade RK
    Curr Pharm Des; 2017; 23(20):2952-2975. PubMed ID: 28292248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hybrid siRNA delivery complex for enhanced brain penetration and precise amyloid plaque targeting in Alzheimer's disease mice.
    Zheng X; Pang X; Yang P; Wan X; Wei Y; Guo Q; Zhang Q; Jiang X
    Acta Biomater; 2017 Feb; 49():388-401. PubMed ID: 27845275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanocarrier systems for delivery of siRNA to ovarian cancer tissues.
    Fathabadi EG; Shelling AN; Al-Kassas R
    Expert Opin Drug Deliv; 2012 Jul; 9(7):743-54. PubMed ID: 22657869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a multifunctional PEG-based gene delivery system containing nuclear localization signals and endosomal escape peptides.
    Moore NM; Sheppard CL; Sakiyama-Elbert SE
    Acta Biomater; 2009 Mar; 5(3):854-64. PubMed ID: 18926782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Promising Nanocarrier for Doxorubicin and siRNA Co-delivery by PDMAEMA-based Amphiphilic Nanomicelles.
    Cheng Q; Du L; Meng L; Han S; Wei T; Wang X; Wu Y; Song X; Zhou J; Zheng S; Huang Y; Liang XJ; Cao H; Dong A; Liang Z
    ACS Appl Mater Interfaces; 2016 Feb; 8(7):4347-56. PubMed ID: 26835788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-density lipoprotein-coupled micelles with reduction and pH dual sensitivity for intelligent co-delivery of paclitaxel and siRNA to breast tumor.
    Zhu WJ; Yang SD; Qu CX; Zhu QL; Chen WL; Li F; Yuan ZQ; Liu Y; You BG; Zhang XN
    Int J Nanomedicine; 2017; 12():3375-3393. PubMed ID: 28490877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endosomal escape pathways for delivery of biologicals.
    Varkouhi AK; Scholte M; Storm G; Haisma HJ
    J Control Release; 2011 May; 151(3):220-8. PubMed ID: 21078351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.